Cellectis and The University of Texas MD Anderson Cancer Center have entered into a research and development alliance aimed at bringing novel cellular immunotherapies to patients suffering from different types of liquid tumors.
3-Sep-2015 1:00 PM EDT Add to Favorites
A researcher at The University of Texas MD Anderson Children’s Cancer Hospital will be awarded $250,000 to further his cancer fighting efforts in a special handprint ceremony Sept. 3.
3-Sep-2015 9:05 AM EDT Add to Favorites
The University of Texas MD Anderson Children’s Cancer Hospital will recognize Childhood Cancer Awareness Month with activities and events geared toward patients and their families, staff and the community. The Be Bold, Go Gold campaign aims to...
31-Aug-2015 8:30 AM EDT Add to Favorites
Internationally Recognized Health Care Leader to Direct MD Anderson Moon Shots Program Prevention Efforts
The University of Texas MD Anderson Cancer Center has appointed former U.S. Public Health Service four-star Admiral Joxel Garcia, M.D. as the inaugural executive director of the cancer prevention and control platform, part of MD Anderson’s Moon...
26-Aug-2015 3:05 PM EDT Add to Favorites
Immatics and MD Anderson Announce Launch of Immatics US, Inc., to Develop Multiple T-Cell and Tcr-Based Adoptive Cellular Therapies
Immatics Biotechnologies GmbH (Immatics) and The University of Texas MD Anderson Cancer Center announced today the launch of Immatics US, Inc., a new company aiming at becoming a global leader in adoptive cellular therapies (ACT) for the treatment...
26-Aug-2015 2:00 AM EDT Add to Favorites
In a first-of-its-kind study, researchers demonstrate a benefit in overall survival among epithelial ovarian cancer (EOC) patients receiving generic heart medications known as beta-blockers. Survival was shown to be greatest among those prescribed...
23-Aug-2015 12:05 AM EDT Add to Favorites
Merck and The University of Texas MD Anderson Cancer Center announced a strategic clinical research collaboration to evaluate Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), in combination with other treatments, such as chemotherapy,...
13-Aug-2015 8:00 AM EDT Add to Favorites
Five globe-trotting, sun-blocking superheroes teach preschoolers about lifelong sun safety in a new curriculum available this summer based on research at The University of Texas MD Anderson Cancer Center.
12-Aug-2015 2:05 PM EDT Add to Favorites
Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.
17-Aug-2015 11:00 AM EDT
A protein called CSN6 has been found to be correlated with poor survival among patients with colorectal cancer, according to a study at The University of Texas MD Anderson Cancer Center.
10-Aug-2015 12:00 PM EDT
MD Anderson Study Predicts New Hepatitis C Drugs Will Place a Dramatic Financial Strain on the Health Care System
The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country’s health care system. The prediction comes from a cost-effectiveness analysis led by...
16-Mar-2015 6:00 PM EDT
Cancer prevention experts at The University of Texas MD Anderson Cancer Center have allied with the CATCH Global Foundation, whose comprehensive child health program reaches children and their families in more than 10,000 educational settings...
18-Feb-2015 10:00 AM EST
30-Oct-2013 8:10 PM EDT
30-Oct-2013 8:00 PM EDT
Expert at The University of Texas M. D. Anderson Cancer Center provide insight to parents based on what we've learned about about the HPV vaccine in the past four years.
12-Jan-2010 3:45 PM EST
Whether you smoke three cigarettes or three packs of cigarettes a day, kicking the habit is difficult. Various nicotine replacement products are on the market to make quitting easier. But which product is right for you? Experts from The University...
11-Nov-2009 4:15 PM EST